PCI Biotech Holding
Biopharma firm evaluating its future after discontinuing its core technology development.
PCIB | OL
Overview
Corporate Details
- ISIN(s):
- NO0010405640
- LEI:
- 5967007LIEEXZXFIGG77
- Country:
- Norway
- Address:
- Ullernchausséen 64, 0379 OSLO
- Website:
- https://www.pcibiotech.no/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
PCI Biotech Holding is a biopharmaceutical company that was focused on developing a proprietary photochemical technology platform. This platform was designed to enhance intracellular drug delivery for therapeutic applications, including immunotherapy and dermatology, and to advance the bioprocessing and manufacturing of viral vectors for gene therapy. In August 2025, the company announced the discontinuation of its core technology development. Consequently, PCI Biotech is currently evaluating its future operations and strategic direction.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-25 15:36 |
Business and Financial Review
PCI Biotech update on future operations
|
English | 3.6 KB | ||
| 2025-08-26 16:14 |
Report Publication Announcement
PCI Biotech: Invitation to first half 2025 results presentation and corporate u…
|
English | 2.3 KB | ||
| 2025-08-22 14:15 |
Major Shareholding Notification
Flaggemelding
|
Norwegian | 411 bytes | ||
| 2025-08-22 11:09 |
Major Shareholding Notification
Flaggemelding
|
Norwegian | 451 bytes | ||
| 2025-08-18 20:39 |
Regulatory News Service
PCI Biotech announces discontinuation of development of the PCL technology and …
|
English | 3.4 KB | ||
| 2025-05-22 09:45 |
Post-Annual General Meeting Information
PCI Biotech: Minutes of Annual General Meeting 2025
|
Norwegian | 449.8 KB | ||
| 2025-05-22 09:45 |
Post-Annual General Meeting Information
PCI Biotech: Minutes of Annual General Meeting 2025
|
English | 866 bytes | ||
| 2025-05-20 20:08 |
Declaration of Voting Results & Voting Rights Announcements
PCI BIotech: Disclosure of voting rights for Chair of the Board
|
English | 1.2 KB | ||
| 2025-04-30 08:00 |
Pre-Annual General Meeting Information
Notice of Annual General Meeting 2025
|
Norwegian | 188.6 KB | ||
| 2025-04-30 08:00 |
Pre-Annual General Meeting Information
Notice of Annual General Meeting 2025
|
Norwegian | 146.9 KB | ||
| 2025-04-30 08:00 |
Pre-Annual General Meeting Information
Notice of Annual General Meeting 2025
|
English | 167.8 KB | ||
| 2025-04-30 08:00 |
Pre-Annual General Meeting Information
Notice of Annual General Meeting 2025
|
English | 208.0 KB | ||
| 2025-04-30 08:00 |
Pre-Annual General Meeting Information
Notice of Annual General Meeting 2025
|
English | 977 bytes | ||
| 2025-04-24 15:30 |
Annual Report (ESEF)
PCI Biotech Holding ASA: Annual Report 2024
|
English | 5.4 MB | ||
| 2025-04-24 15:30 |
Annual Report
PCI Biotech Holding ASA: Annual Report 2024
|
English | 1.2 MB |
Automate Your Workflow. Get a real-time feed of all PCI Biotech Holding filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for PCI Biotech Holding via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
%20Co.%2C%20Ltd/other/SLSBioSpecialty_Lab_Solution_Bio_Co._Ltd-logo.jpg){kind=logo}
